NIKOLUS LAB PRIVATE LIMITED
About
Akums Drugs & Pharmaceuticals Ltd. is the largest India-focused CDMO. We are the largest India-focused CDMO in terms of revenue, production capacity and clients served during the Financial Year 2023 (among CDMOs assessed by F&S) (Source: F&S Report). Akums Drugs offers cutting-edge pharma manufacturing services, delivering safe and effective formulations. Specializing in nutraceutical manufacturing, Akums combines science and natural ingredients to deliver top-quality products. Akums Drugs delivers innovative cosmetics and derma manufacturing services, providing premium skincare solutions. With a focus on precision, Akums Drugs provides API manufacturing services that meet the highest global standards. Akums is India's leading contract development and manufacturing organization (CDMO), delivering high-quality pharmaceutical, nutraceutical, and cosmetic products. With state-of-the-art facilities and unmatched expertise, we ensure innovation, regulatory compliance, and excellence in every formulation. Akums has evolved into a comprehensive solution provider, offering formulation development, bioequivalence studies, clinical trials, and regulatory support, including securing Drug Controller General of India (DCGI) approvals for new Fixed Dose Combinations (FDCs) and molecules. Known for our innovative, technology-driven approach, we develop proprietary formulations tailored to our clients' brands. At Akums, we are committed to delivering excellence through innovation, quality, and trust. As a preferred CDMO partner, we continue to shape the future of healthcare, ensuring safe, effective, and cutting-edge pharmaceutical solutions for a healthier world. Akums integrates eco-friendly initiatives and energy-efficient manufacturing processes, ensuring responsible business operations that contribute to a healthier planet. Leading the Make in India initiative, Akums continues to revolutionize global healthcare by providing high-quality, innovative pharmaceutical solutions with a patient-first approach, strengthening its position as a driving force in the industry.